Clinical Trials Browser

OTHER × Solid Tumors × Clear all

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT03347318 2026-03-04

PROFILING

Other solid neoplasm

Solid Tumors

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06651593 2026-02-17

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07407985 2026-02-12

GK01IIT-TZ03

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT07351903 2026-01-20

GUARDIAN-02

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07178938 2025-11-14

THERANOVA

Phase 2 Not yet recruiting

BreastOther solid neoplasm

Solid Tumors

NCT06066424 2025-10-14

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07128576 2025-09-04

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT02498912 2025-07-31

Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT06951425 2025-05-13

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT02065726 2025-05-01

Whey Protein Supplementation in Cancer Patients

Phase NA Completed

Other solid neoplasm

Solid Tumors

NCT06926751 2025-04-15

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06761417 2025-01-08

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06762327 2025-01-07

Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06755086 2025-01-01

TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors

Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT05231733 2024-10-31

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Solid Tumors

NCT05522582 2024-10-26

Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT06553846 2024-08-14

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06298773 2024-03-07

PROST

Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT03744819 2024-02-06

Biomarkers for Prediction of Tumor Response to Radiotherapy

Other solid neoplasm

Solid Tumors

NCT02506517 2023-08-01

A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT02426892 2023-04-18

Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors

Phase 2 Completed

33 enrolled 14 charts

Other solid neoplasm

Solid Tumors

NCT01379287 2023-02-02

Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02700308 2022-07-28

KYPHO-01

Phase 2 Terminated

Other solid neoplasm

Solid Tumors

NCT02303028 2022-06-28

TOPAZ

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT04937842 2021-06-24

Microtransplantation for Advanced and Relapsed Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT02435927 2021-04-28

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Phase 1 Unknown

Other solid neoplasm

Solid Tumors

NCT02078349 2020-09-10

Phase I Study of KPT330 in Asian Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01548924 2020-04-17

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors

NCT02135510 2020-03-31

MEDEA

Phase 3 Completed

Other solid neoplasm

Solid Tumors

NCT01345513 2020-03-23

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

50 enrolled 8 charts

Other solid neoplasm

Solid Tumors

NCT02058901 2019-07-17

Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02250781 2019-05-22

Oral ONC201 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01949688 2019-03-19

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A24 or A02-positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT02845414 2018-10-03

Study of CD133KDEL Toxin in the Treatment for Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Solid Tumors

NCT02157831 2018-08-17

Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumors

NCT02439489 2018-06-20

Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02619045 2018-03-02

EVAL'COACH

Phase NA Completed

Other solid neoplasm

Solid Tumors

NCT02296879 2018-01-17

A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01485042 2017-09-01

PATH

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00776867 2017-08-01

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00186979 2017-04-26

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01297452 2017-03-31

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02353026 2016-11-18

Phase I Study of Intravenous Artesunate for Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01349296 2016-05-20

BARIS

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02395068 2015-08-19

Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumors

NCT02120118 2015-06-09

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

NCT00770263 2015-06-03

Erlotinib and Temsirolimus for Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors